002826 易明醫藥
按盤價 
21.800 -1.370 (-5.913%)
21.800 -1.370 (-5.913%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.997 | 6.190 | 2.065 | 6.035 | 6.048 |
| 總資產報酬率 ROA (%) | 3.888 | 4.954 | 1.581 | 4.790 | 4.903 |
| 投入資產回報率 ROIC (%) | 4.771 | 6.025 | 1.971 | 5.771 | 5.571 | 邊際利潤分析 |
| 銷售毛利率 (%) | 80.889 | 68.514 | 51.189 | 43.908 | 35.909 |
| 營業利潤率 (%) | 16.281 | 9.434 | 3.524 | 6.505 | 6.704 |
| 息稅前利潤/營業總收入 (%) | 15.713 | 9.083 | 3.313 | 6.435 | 6.741 |
| 淨利潤/營業總收入 (%) | 12.117 | 7.280 | 2.358 | 5.383 | 5.993 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 70.551 | 48.685 | 82.088 | 60.710 | 42.465 |
| 價值變動淨收益/利潤總額(%) | 2.428 | 5.820 | 9.800 | 2.612 | 1.813 |
| 營業外收支淨額/利潤總額(%) | -3.136 | -1.864 | 0.401 | 1.716 | 2.752 | 償債能力分析 |
| 流動比率 (X) | 2.688 | 3.013 | 2.862 | 2.195 | 3.646 |
| 速動比率 (X) | 2.474 | 2.778 | 2.518 | 2.021 | 3.307 |
| 資產負債率 (%) | 23.323 | 19.525 | 19.152 | 26.341 | 12.658 |
| 帶息債務/全部投入資本 (%) | 4.953 | 2.640 | 1.042 | 6.217 | 0.789 |
| 股東權益/帶息債務 (%) | 1,905.526 | 3,659.095 | 9,411.095 | 1,495.803 | 12,480.998 |
| 股東權益/負債合計 (%) | 325.887 | 408.531 | 419.293 | 277.879 | 687.402 |
| 利息保障倍數 (X) | -214.542 | -50.797 | -14.698 | -35.132 | -44.162 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 24.382 | 18.959 | 51.747 | 41.859 | 23.451 |
| 存貨周轉天數 (天) | 136.057 | 87.714 | 57.785 | 29.651 | 21.024 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 22/08/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
